Eikon Therapeutics valued at $860 million in Nasdaq debut
Group 1 - Eikon Therapeutics' shares opened 5.28% below their offer price during their Nasdaq debut [1] - The company's valuation at debut was approximately $860.3 million [1]
Group 1 - Eikon Therapeutics' shares opened 5.28% below their offer price during their Nasdaq debut [1] - The company's valuation at debut was approximately $860.3 million [1]